PL394981A1 - Granulat metanosulfonianu imatinibu, sposób jego wytwarzania i zastosowanie do wytwarzania stalych doustnych preparatów farmaceutycznych - Google Patents

Granulat metanosulfonianu imatinibu, sposób jego wytwarzania i zastosowanie do wytwarzania stalych doustnych preparatów farmaceutycznych

Info

Publication number: PL394981A1
Authority: PL; Poland
Prior art keywords: preparation; pharmaceutical preparations; solid oral; oral pharmaceutical; imatinib mesylate
Prior art date: 2011-05-23

Application number

PL394981A

Other languages

English (en)

Other versions

PL223392B1 (pl

Inventor

Arkadiusz Hejduk

Katarzyna Wierzchucka

Original Assignee

Vipharm Spólka Akcyjna

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-05-23

Filing date

2011-05-23

Publication date

2012-12-03

2011-05-23 Application filed by Vipharm Spólka Akcyjna filed Critical Vipharm Spólka Akcyjna

2011-05-23 Priority to PL394981A priority Critical patent/PL223392B1/pl

2012-12-03 Publication of PL394981A1 publication Critical patent/PL394981A1/pl

2016-10-31 Publication of PL223392B1 publication Critical patent/PL223392B1/pl

Links

238000002360 preparation method Methods 0.000 title 2
239000008187 granular material Substances 0.000 title 1
229960003685 imatinib mesylate Drugs 0.000 title 1
YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 title 1
238000000034 method Methods 0.000 title 1
239000008183 oral pharmaceutical preparation Substances 0.000 title 1
239000007787 solid Substances 0.000 title 1

PL394981A 2011-05-23 2011-05-23 Sposób wytwarzania granulatu zawierającego metanosulfonian imatinibu w odmianie krystalicznej α jako jedyny składnik PL223392B1 (pl)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
PL394981A PL223392B1 (pl)	2011-05-23	2011-05-23	Sposób wytwarzania granulatu zawierającego metanosulfonian imatinibu w odmianie krystalicznej α jako jedyny składnik

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL394981A PL223392B1 (pl)	2011-05-23	2011-05-23	Sposób wytwarzania granulatu zawierającego metanosulfonian imatinibu w odmianie krystalicznej α jako jedyny składnik

Publications (2)

Publication Number	Publication Date
PL394981A1 true PL394981A1 (pl)	2012-12-03
PL223392B1 PL223392B1 (pl)	2016-10-31

Family

ID=47264148

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL394981A PL223392B1 (pl)	2011-05-23	2011-05-23	Sposób wytwarzania granulatu zawierającego metanosulfonian imatinibu w odmianie krystalicznej α jako jedyny składnik

Country Status (1)

Country	Link
PL (1)	PL223392B1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3257499A1 (en)	2016-06-17	2017-12-20	Vipharm S.A.	Process for preparation of imatinib methanesulfonate capsules

2011
- 2011-05-23 PL PL394981A patent/PL223392B1/pl unknown

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3257499A1 (en)	2016-06-17	2017-12-20	Vipharm S.A.	Process for preparation of imatinib methanesulfonate capsules

Also Published As

Publication number	Publication date
PL223392B1 (pl)	2016-10-31

Similar Documents

Publication	Publication Date	Title
IL232158A (en)	2017-02-28	Piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
HUE044778T2 (hu)	2019-11-28	Humán RPE sejt gyógyászati készítmények és alkalmazásaik
IL231536A (en)	2016-09-29	Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
BR112014021103A8 (pt)	2018-01-23	anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
SI3130347T1 (sl)	2020-02-28	Variante polipeptida PH20, formulacije in uporabe le-teh
HRP20181364T1 (hr)	2018-10-19	Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci
EP2819670B1 (en)	2026-05-20	Pharmaceutical Composition and Their Administration
PT2729151T (pt)	2021-05-25	Composição farmacêutica, métodos de tratamento e suas utilizações
HUE041426T2 (hu)	2019-05-28	Terápiás nukleáz-készítmények és eljárások
PL3321355T3 (pl)	2021-12-27	Sposoby i kompozycje do klinicznego pozyskiwania komórek alogenicznych oraz zastosowania terapeutyczne
IL221160A (en)	2015-09-24	4,2,1-triazine-3-amine derivatives, a process for their preparation and use for drug preparation
HUE053113T2 (hu)	2021-06-28	Bardoxolon-metil 2,2-difluorpropionamid-származéka, annak gyógyszerkészítményei és polimorfjai bizonyos betegségek kezelésében történõ alkalmazásra
BR112015003376A2 (pt)	2017-07-04	composto ou sal farmaceuticamente aceitável do mesmo , composição farmacêutica e usos de quantidade eficiente
BR112014009634A2 (pt)	2017-05-09	preparação e agente terapêutico
BR112014012005A2 (pt)	2017-12-19	composições, métodos, formulação farmacêutica e artigo
BR112012022878A2 (pt)	2016-06-14	composto, composição farmacêutica, uso do compostos e método de tratamento
IL233757A0 (en)	2014-09-30	Anti '1m e-gi antibodies and methods of using them
CL2014003232A1 (es)	2015-03-13	Formulaciones y métodos para la administración vaginal de antiprogestinas.
PL2760878T3 (pl)	2016-04-29	Pochodne estra-1,3,5(10),16-tetraeno-3-karboksyamidowe, sposób ich wytwarzania, preparaty farmaceutyczne, które je zawierają, i ich zastosowanie do wytwarzania leków
BR112014010290A2 (pt)	2017-05-02	composição farmacêutica, métodos, composições e usos
IL232325A0 (en)	2014-06-30	18-methyl-7,6-methylene-3-oxo-17-paragan-4-en-21, 17b-carbolactones, pharmaceutical preparations containing these compounds and their use for the treatment of endometrial disease
PL2512453T5 (pl)	2025-07-07	Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania
ME03483B (me)	2020-01-20	Amorfni letermovir i njegove čvrste farmaceutske formulacije za oralno davanje
SI2655375T1 (sl)	2015-03-31	Derivati pirimidinona, njihova priprava in njihova farmacevtska uporaba
ITTO20110641A1 (it)	2012-01-16	Composizioni farmaceutiche e metodi di trattamento